SignalGeopolitics
Pro-life group says Trump admin didn't give key abortion drug commitments before Overton FDA nomination pulled
Pro-life group cites lack of abortion drug commitments before Overton FDA nomination pulled.
Context
What happened: The White House withdrew Heidi Overton's nomination to lead the FDA one day before a Senate committee vote. A pro-life group said it had asked the Senate to hold up her confirmation until the administration made commitments on abortion drug policy.
Key numbers: The FDA said study results are expected in December 2026 and a final
Why it matters: Susan B. Anthony Pro-Life America wants the next nominee to commit to ending mail-order access to abortion drugs and changing how the agency studies their safety. Sen. Bill Cassidy said he believed she could have been confirmed.
What changed
The White House withdrew Heidi Overton's nomination to lead the FDA one day before a Senate committee vote. A pro-life group said it had asked the Senate to hold up her confirmation until the administration made commitments on abortion drug policy.
Why it matters
Susan B. Anthony Pro-Life America wants the next nominee to commit to ending mail-order access to abortion drugs and changing how the agency studies their safety. Sen. Bill Cassidy said he believed she could have been confirmed.